Ritonavir Impurity F is a structurally related synthetic byproduct arising from the amidation step in Ritonavir production. It retains the core naphthalene sulfonamide scaffold and pyrazine-fused tetrahydrofuran ring system but features an additional methylene group (-CH2-) in the side chain adjacent to the sulfonamide linkage, resulting from a failed cyclization event. This impurity exhibits a truncated ester functionality compared to the parent drug, replacing the critical ฮณ-lactam moiety with a saturated carbonyl-terminated aliphatic chain. The compound demonstrates moderate hydrophobicity due to its extended aliphatic substituents and serves as a critical HPLC reference standard for monitoring process consistency in antiretroviral drug manufacturing.
